Literature DB >> 9254899

Plasminogen activator and matrix metalloproteinase production and extracellular matrix degradation by rat prostate cancer cells in vitro: correlation with metastatic behavior in vivo.

P H Quax1, A C de Bart, J A Schalken, J H Verheijen.   

Abstract

BACKGROUND: The plasminogen activation (PA) and metalloproteinase (MMP) system are involved in tumor cell migration and invasion.
METHODS: The proteolytic activity of cell lines originating from the rat Dunning R-3327 prostate tumor was analyzed by measuring in vitro extracellular matrix degradation, enzyme activity, and mRNA levels of enzymes, inhibitors, and receptors, and compared with their known metastatic behavior in vivo.
RESULTS: Only the highly metastatic sublines AT-3, MATLu, and MATLyLu showed a high extracellular matrix degradation mediated by urokinase-type plasminogen activator (u-PA). Relatively high levels of u-PA were present in the aggressive cell lines. u-PA receptor mRNA was produced in all cells, and all but AT-1 produced LDL-receptor-related-protein (LRP) mRNA. t-PA mRNA was only found in HIF and MATLu. In gelatin, zymography lysis was observed at 72 kD and 74-76 kD in MATLu and MATLyLu cells, respectively. MMP-2 mRNA was present in all cell lines except AT-1 and AT-2, and MMP-3 mRNA was present in AT-2, AT-3, and MATLu.
CONCLUSIONS: These in vitro experiments show that in different rat prostate cancer sublines, proteolytic activity and u-PA-mediated extracellular matrix degradation correlate with their known metastatic behavior in vivo.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9254899     DOI: 10.1002/(sici)1097-0045(19970801)32:3<196::aid-pros6>3.0.co;2-j

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  8 in total

1.  Interactions between human osteoblasts and prostate cancer cells in a novel 3D in vitro model.

Authors:  Shirly Sieh; Amy A Lubik; Judith A Clements; Colleen C Nelson; Dietmar W Hutmacher
Journal:  Organogenesis       Date:  2010 Jul-Sep       Impact factor: 2.500

Review 2.  Extracellular Vesicle-Mediated Bone Remodeling and Bone Metastasis: Implications in Prostate Cancer.

Authors:  Kalyani C Patil; Carolina Soekmadji
Journal:  Subcell Biochem       Date:  2021

3.  Establishment and characterization of a cholangiocarcinoma cell line (RMCCA-1) from a Thai patient.

Authors:  Panthip Rattanasinganchan; Kawin Leelawat; Sa-ard Treepongkaruna; Chintana Tocharoentanaphol; Somboon Subwongcharoen; Tuangporn Suthiphongchai; Rutaiwan Tohtong
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

4.  Associations of IgG N-linked oligosaccharide chains and proteases in sera of prostate cancer patients with and without alpha2-macroglobulin deficiency.

Authors:  Yuhsaku Kanoh; Shin Egawa; Shiro Baba; Tohru Akahoshi
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

Review 5.  Targeting bone physiology for the treatment of metastatic prostate cancer.

Authors:  Karen A Autio; Michael J Morris
Journal:  Clin Adv Hematol Oncol       Date:  2013-03

6.  Serum matrix metalloproteinase-2 levels indicate blood-CSF barrier damage in patients with infectious meningitis.

Authors:  Yuhsaku Kanoh; Tadashi Ohara; Motonari Kanoh; Tohru Akahoshi
Journal:  Inflammation       Date:  2008-01-10       Impact factor: 4.092

7.  The role of serine proteases and serine protease inhibitors in the migration of gonadotropin-releasing hormone neurons.

Authors:  Paola T Drapkin; Denis Monard; Ann-Judith Silverman
Journal:  BMC Dev Biol       Date:  2002-02-05       Impact factor: 1.978

8.  In vitro and in vivo anti-cancer effects of hibernating common carp (Cyprinus carpio) plasma on metastatic triple-negative breast cancer.

Authors:  Mojtaba Golpich; Elham Amini; Amirhosein Kefayat; Mehrafarin Fesharaki; Jamal Moshtaghian
Journal:  Sci Rep       Date:  2022-02-21       Impact factor: 4.996

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.